Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes.
Saved in:
| Title: | Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes. |
|---|---|
| Authors: | Weir, Matthew R.1 (AUTHOR) Mweir@som.umaryland.edu, Chen, Yen-Wen2 (AUTHOR), He, Jinghua2 (AUTHOR), Bookhart, Brahim2 (AUTHOR), Campbell, Alicia2 (AUTHOR), Ashton, Veronica2 (AUTHOR) |
| Source: | Diabetes Therapy. Dec2021, Vol. 12 Issue 12, p3167-3186. 20p. |
| Database: | Academic Search Ultimate |
| ISSN: | 18696953 |
|---|---|
| DOI: | 10.1007/s13300-021-01161-4 |
